Home > Boards > Free Zone > User's Groups > Awesome Stocks

>>> Edwards Lifesciences Corporation (EW) provides products and

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
gfp927z Member Profile
 
Followed By 61
Posts 23,003
Boards Moderated 73
Alias Born 03/22/05
160x600 placeholder
Visa's Planned Purchase of Plaid Faces Antitrust Scrutiny at the Justice Department -- 3rd Update
Visa Inc.'s $5.3 billion deal to buy a key player in the financial-technology space is in jeopardy because of antitrust concerns, according to people familiar with the matter.
Top Company News of the Day
Bayer, BASF Weedkillers Cleared by EPA for Another Five Years
Lawmakers Want to Protect Local Newspapers From Google, Facebook -- 2nd Update
Microsoft's Earnings Continue to Ride Pandemic-Fueled Demand for Cloud, Videogaming -- 3rd Update
Justice Department Cites Treatment of Hunter Biden Articles in Call to Change Law Protecting Online Platforms
Microsoft's Earnings Continue to Ride Pandemic-Fueled Demand for Cloud, Videogaming -- 2nd Update
Top Stories of the Day
Eli Lilly Earnings, Halted Covid-19 Drug Trial Disappoint Investors -- Update
Dow, S&P 500 Slide After Big Selloff
Visa's Planned Purchase of Plaid Faces Antitrust Scrutiny at the Justice Department -- 2nd Update
Microsoft's Earnings Continue to Ride Pandemic-Fueled Demand for Cloud, Videogaming -- Update
Stock Investors' Bets Eye a Biden Victory, Robust Stimulus -- Update
Microsoft's Earnings Continue to Ride Pandemic-Fueled Demand for Cloud, Videogaming
Chubb's Net Income Increases
U.S. Stocks Finish Mixed
Pfizer Says Covid-19 Vaccine Late-Stage Trial Almost Fully Enrolled -- 3rd Update
Facebook Warns of Foreign Operators Exaggerating Their Election-Interference Abilities
Wheat Slides Amid Election Jitters
WTO Is Poised to Pick Its First Female Leader
Eli Lilly Earnings, Halted Covid-19 Drug Trial Disappoint Investors
U.S. Stocks Waver After Selloff
gfp927z   Sunday, 03/17/19 11:06:26 PM
Re: None
Post # of 30 
>>> Edwards Lifesciences Corporation (EW) provides products and technologies for structural heart disease and critical care monitoring in the United States and internationally. It offers transcatheter heart valve therapy products comprising transcatheter aortic valve replacement, and transcatheter mitral and tricuspid therapies for the nonsurgical replacement of heart valves. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; and cardiac cannula devices, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; pulmonary artery catheters; Oximetry Central Venous catheters, as well as clinical monitoring platforms that display a patient's physiological status; Acumen Hypotension Prediction Index, an advanced algorithm that indicates the likelihood of a patient developing hypotension; and disposable pressure monitoring devices and closed blood sampling systems to protect patients and clinicians from infection. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.

<<<


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences